Xia, Z. et al. Dynamic analyses of alternative polyadenylation from RNA-Seq reveal landscape of 3′ UTR usage across 7 tumor types. Nat. Commun. 5, 5274, (2014).
Masamha, C. P. et al. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 510, 412–416 (2014).
Zhang, S. & Yu, D. PI(3)king apart PTEN’s role in cancer. Clin. Cancer Res. 16, 4325–4330 (2010).
Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033–1038 (2010).
Mayr, C. & Bartel, D. P. Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673–684 (2009).
Fu, Y. et al. Differential genome-wide profiling of tandem 3′ UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome Res. 21, 741–747 (2011).
Lin, Y. et al. An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res. 40, 8460–8471 (2012).
Morris, A. R. et al. Alternative cleavage and polyadenylation during colorectal cancer development. Clin. Cancer 18, 5256–5266 (2012).
Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948–962 (2013).
Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353–358 (2011).
Thomson, D. W. & Dinger, M. E. Endogenous microRNA sponges: evidence and controversy. Nat. Rev. Genet. 17, 272–283 (2016).
Tay, Y. et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344–357 (2011).
Sumazin, P. et al. An extensive microRNA-mediated network of RNA–RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147, 370–381 (2011).
Ala, U. et al. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc. Natl Acad. Sci. USA 110, 7154–7159 (2013).
Swanton, C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 72, 4875–4882 (2012).
Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834–838 (2005).
Hausser, J. & Zavolan, M. Identification and consequences of miRNA–target interactions — beyond repression of gene expression. Nat. Rev. Genet. 15, 599–612 (2014).
Mets, E. et al. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia. Haematologica 99, 1326–1333 (2014).
Selcuklu, S. D. et al. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J. Biol. Chem. 287, 29516–29528 (2012).
Tian, B. & Manley, J. L. Alternative cleavage and polyadenylation: the long and short of it. Trends Biochem. Sci. 38, 312–320 (2013).
Mueller, A. A., Cheung, T. H. & Rando, T. A. All’s well that ends well: alternative polyadenylation and its implications for stem cell biology. Curr. Opin. Cell Biol. 25, 222–232 (2013).
Li, L. et al. 3′UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network. Sci. Rep. 4, 5406 (2014).
Tay, Y., Rinn, J. & Pandolfi, P. P. The multilayered complexity of ceRNA crosstalk and competition. Nature 505, 344–352 (2014).
Wang, Y. et al. The emerging function and mechanism of ceRNAs in cancer. Trends Genet. 32, 211–224 (2016).
Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 (2005).
Papadopoulos, G. L., Reczko, M., Simossis, V. A., Sethupathy, P. & Hatzigeorgiou, A. G. The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res. 37, D155–D158 (2009).
Xiao, F. et al. miRecords: an integrated resource for microRNA–target interactions. Nucleic Acids Res. 37, D105–D110 (2009).
Hsu, S.-D. et al. miRTarBase update 2014: an information resource for experimentally validated miRNA–target interactions. Nucleic Acids Res. 42, D78–D85 (2014).
Dvinge, H. et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497, 378–382 (2013).
Hamilton, M. P. et al. Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nat. Commun. 4, 2730 (2013).
Goldman, M. et al. The UCSC Cancer Genomics Browser: update 2013. Nucleic Acids Res. 41, D949–D954 (2013).
Friedman, J. M., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1–22 (2010).
Kim, S., Baladandayuthapani, V. & Lee, J. J. Prediction-oriented marker selection (PROMISE): with application to high-dimensional regression. Stat. Biosci 9, 217–245 (2016).
Bayerlová, M. et al. Newly constructed network models of different WNT signaling cascades applied to breast cancer expression data. PLoS ONE 10, 1–19 (2015).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 (2012).
Krutzfeldt, J. et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438, 685–689 (2005).
Tenenbaum, S. A., Lager, P. J., Carson, C. C. & Keene, J. D. Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26, 191–198 (2002).